Table 4 Baseline characteristics in non-do not intubate (DNI) and DNI groups
Non-DNI group (n = 39) | DNI group (n = 81) | |||||
|---|---|---|---|---|---|---|
Intermittent (n = 28) | Continuous (n = 11) | P-value | Intermittent (n = 44) | Continuous (n = 37) | P-value | |
Gender (male/female) | 22/6 | 8/3 | 0.70 | 26/18 | 28/9 | 0.11 |
Age (y) | 71.1 ± 10.9 | 60.5 ± 14.3 | 0.035 | 80.5 ± 8.1 | 74.9 ± 9.9 | 0.010 |
Duration of NIV (d) | 4.5 ± 4.5 | 9.7 ± 11.7 | 0.044 | 7.0 ± 4.7 | 8.5 ± 5.3 | 0.12 |
Duration of continuous sedation (d) | − | 7.7 ± 12.0 | − | − | 5.1 ± 3.2 | − |
Managing ward | ||||||
general ward | 6/28 (21 %) | 2/11 (18 %) | 0.82 | 18/44 (41 %) | 9/37 (24 %) | 0.11 |
emergency ward | 17/28 (61 %) | 7/11 (64 %) | 0.87 | 23/44 (52 %) | 21/37 (57 %) | 0.69 |
ICU | 5/28 (18 %) | 2/11 (18 %) | 0.98 | 3/44 (7 %) | 7/37 (19 %) | 0.10 |
Respiratory failure (without/with hypercapnia)a | 18/5 | 9/1 | 0.42 | 14/28 | 23/11 | 0.003 |
P/F ratio (mmHg) | 114 ± 49 | 108 ± 62 | 0.49 | 148 ± 80 | 111 ± 51 | 0.032 |
NIV setting (CPAP/ PSV) | 15/13 | 7/4 | 0.57 | 13/31 | 11/26 | 0.99 |